dc.contributor.author | Radley, Andrew | |
dc.contributor.author | de Bruin, Marijn | |
dc.contributor.author | Inglis, Sarah K. | |
dc.contributor.author | Donnan, Peter T. | |
dc.contributor.author | Hapca, Adrian | |
dc.contributor.author | Barclay, Stephen T. | |
dc.contributor.author | Fraser, Andrew | |
dc.contributor.author | Dillon, John F. | |
dc.date.accessioned | 2020-12-08T00:06:10Z | |
dc.date.available | 2020-12-08T00:06:10Z | |
dc.date.issued | 2020-09-01 | |
dc.identifier | 170272781 | |
dc.identifier | 077ae848-4e81-4b10-99cf-a6fe9b10d249 | |
dc.identifier | 85086946581 | |
dc.identifier | 000562267100019 | |
dc.identifier.citation | Radley , A , de Bruin , M , Inglis , S K , Donnan , P T , Hapca , A , Barclay , S T , Fraser , A & Dillon , J F 2020 , ' Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy : A pragmatic cluster randomised trial ' , The Lancet Gastroenterology & Hepatology , vol. 5 , no. 9 , pp. 809-818 . https://doi.org/10.1016/S2468-1253(20)30120-5 | en |
dc.identifier.issn | 2468-1253 | |
dc.identifier.uri | https://hdl.handle.net/2164/15472 | |
dc.description | Funding: Partnership between the Scottish Government, Gilead Sciences, and Bristol-Myers Squib. | en |
dc.format.extent | 10 | |
dc.format.extent | 416939 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Lancet Gastroenterology & Hepatology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | GLOBAL PREVALENCE | en |
dc.subject | CARE | en |
dc.subject | INTERVENTIONS | en |
dc.subject | INFECTION | en |
dc.subject | BARRIERS | en |
dc.subject | PEOPLE | en |
dc.subject | HCV | en |
dc.subject | R Medicine (General) | en |
dc.subject | Gastroenterology | en |
dc.subject | Hepatology | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R1 | en |
dc.title | Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy : A pragmatic cluster randomised trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1016/S2468-1253(20)30120-5 | |
dc.date.embargoedUntil | 2020-12-08 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85086946581&partnerID=8YFLogxK | en |
dc.identifier.vol | 5 | en |
dc.identifier.iss | 9 | en |